References

Inhibiting roles of Foxa2 in liver cancer cell migration and invasion by transcriptionally suppressing microrna-103a-3p and activating the grem2/lats2/yap axis

10.1007/s10616-021-00475-2 · 2021 · External reference

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21834 · 2024 · External reference

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21660 · 2021 · External reference

Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma

10.4254/wjh.v9.i6.300 · 2017 · External reference

Effect of phenylethanol glycosides from Cistanche deserticola on autophagy of tumor cells in H22 tumor-bearing mice

10.1155/2022/3993445 · 2022 · External reference

An investigation on the anti-liver cancer effect of Cistanche, Carcinog.

2018 · External reference

Effect of Cistanche deserticola phenylethanol glycoside on proliferation and apoptosis of HEPG2 cells in viro

10.3969/j.issn.1004-616x.2019.04.005 · 2021 · External reference

Sorafenib plus capecitabine for patients with advanced hepatocellular caicinoma

2008 · External reference

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

10.1038/s41392-020-0187-x · 2020 · External reference

Effect and mechanism of celastrol on the proliferation of hepatocellular carcinoma HEPG2 cells by activating AMPK signal pathway

10.19962/j.cnki.issn1008-049x.2021.11.001 · 2021 · External reference

The combination sorafenib-raloxifene-loratadine as a novel potential therapeutic approach against human livver cancer

10.21873/invivo.13190 · 2023 · External reference

Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib

10.3892/or.2018.6552 · 2018 · External reference

Effects of sorafenib and quercetin alone or in combination in treating hepatocellular carcinoma: in vitro and in vivo approaches

10.3390/molecules27228082 · 2022 · External reference

Gut microbiome and health: mechanistic insights

10.1136/gutjnl-2021-326789 · 2022 · External reference

The gut microbiome, antitumor immunity, and liver cancer

10.21037/hbsn.2018.11.09 · 2019 · External reference

The gut-liver axis and the intersection with the microbiome

10.1038/s41575-018-0011-z · 2018 · External reference

The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma

10.4161/gmic.29599 · 2014 · External reference

Modulation of the gut microbiome to improve clinical outcomes in hepatocellular carcinoma

10.3390/cancers14092099 · 2022 · External reference

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

10.1038/s41467-020-20422-7 · 2021 · External reference

Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease

10.1002/hep.30036 · 2019 · External reference

The gut microbiome and liver cancer: mechanisms and clinical translation

10.1038/nrgastro.2017.72 · 2017 · External reference

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4

10.1016/j.ccr.2012.02.007 · 2012 · External reference

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

10.1038/nature12347 · 2013 · External reference

Effects of total glycosides of Cistanche deserticola on proliferation, apoptosis and expression of Wnt/β-catenin signaling pathway related protein of HEPG2 cells

10.13386/j.issn1002-0306.2022100297 · 2023 · External reference

Optimization of aqueous extraction preparation technology of Cistanche deserticola by response surface methodology and its activity research

10.13386/j.issn1002-0306.2022050033 · 2023 · External reference

Effect of total glycosides of Cistanche deserticola on HEPG2 hepatoma-bearing mice

10.3389/fnut.2023.1117364 · 2024 · External reference

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5

10.1158/0008-5472.can-06-1377 · 2006 · External reference

Sorafenib-irinotecan sequential therapy augmented the anti-tumor efficacy of monotherapy in hepatocellular carcinoma cells HEPG2

10.4149/neo_2015_022 · 2015 · External reference

Transcriptome analysis of tumor-derived mesenchymal progenitor cells shows that CHST15 is a fibrosis regulator of retroperitoneal liposarcoma

10.21037/atm-22-963 · 2022 · External reference

Rhubarb granule promotes diethylnitrosamine-induced liver tumorigenesis by activating the oxidative branch of pentose phosphate pathway via G6pd in rats

10.1016/j.jep.2021.114479 · 2021 · External reference

Effect of total glycosides of Cistanche deserticola on the energy metabolism of human HEPG2 cells

10.3389/fnut.2023.1117364 · 2023 · External reference

Potential impacts of prebiotics and probiotics on cancer prevention

10.2174/1871520621999201210220442 · 2022 · External reference

Diagnostic value of combined detection of serum AFP, AFU and ALP in primary liver cancer

10.3969/j.issn.1673-4934.2017.03.012 · 2017 · External reference

F. Yang. The dynamic changes of β-catenin in the process of mice liver cancer formation chemically

2013 · External reference

Wnt/β-catenin signaling and disease

10.1016/j.cell.2012.05.012 · 2012 · External reference

Wnt/β-catenin signaling in liver development, homeostasis, and pathobiology

10.1146/annurev-pathol-020117-044010 · 2018 · External reference

10.1016/j.bbrc.2020.03.050

10.1016/j.bbrc.2020.03.050 · External reference

Echinacein inhibits the proliferation of acute myeloid leukemia cells by suppressing SOX4/Wnt/β-catenin signal

10.13431/j.cnki.immunol.j.20200023 · 2020 · External reference

Expression of β-catenin and its significance in the L2, WB, HEPG2, SMCC cells

2011 · External reference

Study on anti-hepatoma effect of ginsenoside RH2 and mechanism of degradation of β-catenin through activating GSK-3β

2016 · External reference

The algal polysaccharide ulvan suppresses growth of hepatoma cells

10.1002/fft2.13 · 2020 · External reference

Influences of Roucongrong (Herba Cistanchis) on hematopoietic function and immune function in tumor-bearing mice after chemotherapy

2010 · External reference

Challenges in liver cancer and possible treatment approaches

10.1016/j.bbcan.2019.188314 · 2020 · External reference

Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer

10.2147/ijn.s73322 · 2014 · External reference

Effect of Yipi Yanggang decoction on BFGF, VEGF, AFP-l3 and immune function in patients undergoing tace surgery for primary liver cancer

10.13194/j.issn.1673-842x.2022.01.018 · 2022 · External reference

Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells

10.1016/j.canlet.2018.07.001 · 2018 · External reference

Cd40 agonist-induced IL-12p40 potentiates hepatotoxicity

10.1136/jitc-2020-000624 · 2020 · External reference

NF-κB: linking inflammation and immunity to cancer development and progression

10.1038/nri1703 · 2005 · External reference

Research progress on the role of immunosuppressive cells and cytokines in anti-tumor immune response in tumor microenvironment

2019 · External reference

A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class Ⅰ and transporter associated with antigen processing 1/2 in human melanoma cells

10.4049/jimmunol.173.3.1731 · 2004 · External reference

Type 3 cytokines in liver fibrosis and liver cancer

10.1016/j.cyto.2018.07.028 · 2019 · External reference

Natural killer cell-derived IL-10 prevents liver damage during sustained murine cytomegalovirus infection

10.3389/fimmu.2019.02688 · 2019 · External reference

Cytokines and tumor immunity

2013 · External reference

Summary of bi-shrnafurin/GM-CSF augmented autologous tumor cell immunotherapy (fangTM) in advanced cancer of the liver

10.1159/000360993 · 2014 · External reference

Role and clinical application of granulocyte-macrophage colony-stimulating factor in tumor immunotherapy

10.16150/j.1671-2870.2021.04.015 · 2021 · External reference

From allergy to cancer—clinical usefulness of eotaxins

10.3390/cancers13010128 · 2021 · External reference

Ip-10 (CXCL10) can trigger emergence of dormant breast cancer cells in a metastatic liver microenvironment

10.3389/fonc.2021.676135 · 2021 · External reference

The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia

10.1002/jlb.64.4.494 · 1998 · External reference

Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils

10.1177/153537020523000809 · 2005 · External reference

Dietary supplementation with casein/cyanidin-3-O-glucoside nanoparticles alters the gut microbiota in high-fat fed C57BL/6 mice

10.1016/j.foodchem.2023.135494 · 2023 · External reference

A designed self-microemulsion delivery system for dihydromyricetin and its dietary intervention effect on high-fat-diet fed mice

10.1016/j.foodchem.2022.132954 · 2022 · External reference

Inhibitory mechanism of muscone in liver cancer involves the induction of apoptosis and autophagy

10.3892/or.2020.7484 · 2020 · External reference

Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma

10.5114/ceh.2019.89478 · 2019 · External reference

Aberrant lipid metabolism as a therapeutic target in liver cancer

10.1080/14728222.2019.1615883 · 2019 · External reference

Induction of apoptosis by metabolites of Rhei Radix et Rhizoma (Da Huang): a review of the potential mechanism in hepatocellular carcinoma

10.3389/fphar.2022.806175 · 2022 · External reference

Physcion induces apoptosis through triggering endoplasmic reticulum stress in hepatocellular carcinoma

10.1016/j.biopha.2018.01.148 · 2018 · External reference

Regenerative and protective actions of the GHK-CU peptide in the light of the new gene data

10.3390/ijms19071987 · 2018 · External reference

A potent ion channel blocker, hydroquinidine, exhibits strong anti-cancer activity on colon, pancreatic, and hepatocellular cancer cells

10.1007/s11033-023-08245-3 · 2023 · External reference

Anti-inflammatory coumarins from Paramignya trimera

10.1080/13880209.2017.1296001 · 2017 · External reference

Α-tocopherol attenuates NF-κB activation and pro-inflammatory cytokine IL-6 secretion in cancer-bearing mice

10.1042/bsr20100137 · 2011 · External reference

26-week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-RASH2 transgenic mice

10.1007/s00204-010-0536-6 · 2011 · External reference

Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives

10.1093/jambio/lxad221 · 2023 · External reference

Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma

10.1038/s41598-023-34765-w · 2023 · External reference

Assessment of the safety and probiotic properties of Roseburia intestinalis: a potential “next generation probiotic”

10.3389/fmicb.2022.973046 · 2022 · External reference

Microbiota in health and diseases

10.1038/s41392-022-00974-4 · 2022 · External reference

Association of gut microbiome and primary liver cancer: a two-sample mendelian randomization and case-control study

10.1111/liv.15466 · 2023 · External reference

Association of disease condition with changes in intestinal flora, and plasma endotoxin and vascular endothelial growth factor levels in patients with liver cancer

10.26355/eurrev_202004_20822 · 2020 · External reference